Showing results (171-180 of 202) with videos related to
Sort By:
Pageof 21
Haematologica|July 3, 2025
Hematopoietic stem cell transplantation is effective in achieving long-term survival for post-aplastic anemia myeloid neoplasms: the EBMT Severe Aplastic Anemia ReportPedro Henrique Prata, Dirk-Jan Eikema, Brian Piepenbroek, et al.Journal of Hematology & Oncology|February 21, 2026
Allogeneic stem cell transplantation for major T-cell lymphoma entities: an analysis of the EBMT-lymphoma working partyEvgenii Shumilov, Maud Ngoya, Philipp Berning, et al.The Lancet. Haematology|December 7, 2023
Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working GroupNicolaus Kröger, Andrea Bacigalupo, Tiziano Barbui, et al.Bone Marrow Transplantation|August 12, 2023
Current incidence, severity, and management of veno-occlusive disease/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT Transplant Complications Working Party studyTapani Ruutu, Christophe Peczynski, Mohamed Houhou, et al.Bone Marrow Transplantation|January 22, 2024
Impact of post-transplant cyclophosphamide (PTCy)-based prophylaxis in matched sibling donor allogeneic haematopoietic cell transplantation for patients with myelodysplastic syndrome: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMTMaría Queralt Salas, Diderik-Jan Eikema, Linda Koster, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2024
Human Leukocyte Antigen Mismatching and Survival in Contemporary Hematopoietic Cell Transplantation for Hematologic MalignanciesEsteban Arrieta-Bolaños, Edouard F Bonneville, Pietro Crivello, et al.Bone Marrow Transplantation|March 16, 2024
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMTMarie Robin, Simona Iacobelli, Linda Koster, et al.Bone Marrow Transplantation|April 16, 2024
Outcomes of allogeneic haematopoietic cell transplantation for myelofibrosis in children and adolescents: the retrospective study of the EBMT Paediatric Diseases WPJacek Wachowiak, Jacques-Emmanuel Galimard, Arnaud Dalissier, et al.Blood|September 27, 2019
Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study GroupFrank G Rücker, Mridul Agrawal, Andrea Corbacioglu, et al.American Journal of Hematology|February 15, 2024
Splenic irradiation for myelofibrosis prior to hematopoietic cell transplantation: A global collaborative analysisNico Gagelmann, Gabriela S Hobbs, Edoardo Campodonico, et al.Pageof 21